PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-6.81%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.56B
AUM Growth
+$2.56B
(-1.1%)
Cap. Flow
+$231M
Cap. Flow
% of AUM
9.01%
Top 10 Holdings %
Top 10 Hldgs %
34.93%
Holding
85
New
16
Increased
21
Reduced
12
Closed
9
Top Buys
| 1 |
Merck
MRK
|
$88.6M |
| 2 |
Axsome Therapeutics
AXSM
|
$52.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$50M |
| 4 |
Veeva Systems
VEEV
|
$40.1M |
| 5 |
argenx
ARGX
|
$39.7M |
Top Sells
| 1 |
Outset Medical
OM
|
$128M |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$34.1M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$28.1M |
| 4 |
Heron Therapeutics
HRTX
|
$20.1M |
| 5 |
HCA Healthcare
HCA
|
$20.1M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Financials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$140B
| – | – | -249,884 | Closed | -$14.9M |
|
|
77
HCA Healthcare
HCA
$94.5B
| – | – | -80,128 | Closed | -$20.1M |
|
|
78
Heron Therapeutics
HRTX
$207M
| – | – | -3,512,348 | Closed | -$20.1M |
|
79
Standard BioTools
LAB
$481M
| – | – | -980,505 | Closed | -$3.52M |
|
|
80
Outset Medical
OM
$247M
| – | – | -2,810,686 | Closed | -$128M |
|
|
CANO
81
DELISTED
Cano Health, Inc.
CANO
| – | – | -1,301,937 | Closed | -$8.27M |
|
|
SRRA
82
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – | -1,062,888 | Closed | -$34.1M |
|